News
- Author:
- Liam Davenport
Publish date: September 14, 2021
The data “strengthen prior evidence and provide new insights into site-specific carcinogenesis as well as indirect support for the role of gut micr...
News
- Author:
- Liam Davenport
Publish date: September 13, 2021
Enrollment in lung cancer clinical trials fell during the early months of the COVID-19 pandemic, but increased af...
News
- Author:
- Liam Davenport
Publish date: September 13, 2021
“As lung cancer professionals, we can mitigate the effects of air pollution on causing lung cancer by speaking out for clean energy standards.”
News
- Author:
- Liam Davenport
Publish date: September 10, 2021
Microwave ablation was associated with a “low rate of device-related adverse events and no serious adverse events...
News
- Author:
- Liam Davenport
Publish date: September 3, 2021
The diabetes drug metformin, despite a wealth of epidemiological and lab data suggesting otherwise, does not impr...
News
- Author:
- Liam Davenport
Publish date: August 9, 2021
Participants with diabetes faced a 67% increased risk of infection-related hospitalization, compared with those w...
News
- Author:
- Liam Davenport
Publish date: July 8, 2021
“We now want to find out if there is a link between antibiotic use and changes in the microbiome which can make the colon more susceptible to cance...
News
- Author:
- Liam Davenport
Publish date: June 29, 2021
Instead of starting very-high-risk patients unlikely to reach goal on a statin alone, clinicians should immediately reach for combination statin-ez...
News
- Author:
- Liam Davenport
Publish date: June 15, 2021
Determining if PCI patients have just one or more guideline-based risk features predicts their odds of ischemic events, and can be used to tailor a...
News
- Author:
- Liam Davenport
Publish date: June 10, 2021
The model “predicts dying ... for every single day for the last 3 months of life,” Dr. Coyle said.
News
- Author:
- Liam Davenport
Publish date: June 9, 2021
Tool could predict the need for admission or oxygen therapy, as well as the risk of death.
News
- Author:
- Liam Davenport
Publish date: June 3, 2021
Anti–apo A-I antibodies appear to be common in patients with NAFLD and may drive both fat deposits and proinflammatory effects in liver cells, alth...
News
- Author:
- Liam Davenport
Publish date: May 24, 2021
This is the “first global phase 3 trial using an immune checkpoint inhibitor to show a disease-free survival outc...
News
- Author:
- Liam Davenport
Publish date: May 21, 2021
“Relatlimab plus nivolumab is a potential novel treatment option for this patient population,” said lead research...
News
- Author:
- Liam Davenport
Publish date: May 14, 2021
Copeptin has been shown previously to be a predictor of outcomes in somatic diseases.
